No adverse effects were noted in clinical trials (ulcerative colitis, phase II) [84,85], and in toxicological studies, a lethal dose (LD1) was not achieved (for review, see [11,12,13,14,24,25])
Side effects are generally milder than tesamorelin some users experience mild water retention, occasional wrist/hand numbness, or post-injection flushing, but these tend to be less pronounced
AOD 9604 is often compared with other metabolic and growth hormone-related peptides because of its unique non-secretagogue mechanism
Its rapid absorption and broad health benefits make it a valuable addition to wellness programs, stress-reduction plans, and performance optimization therapies
In this study, we aimed to investigate the relationship between LMNA mutations and muscular laminopathy by establishing six different LMNA transgenic zebrafish lines